The EU is about to stop a precedent-setting initiative that was designed to tackle a common side effect of drugs, their impact on aquatic life. The landmark regulations intended on cleaning up Europe’s waterways of pharmaceuticals is likely to be quashed when it reaches a key vote in the EU Parliament next week.
The proposal would limit the concentrations in water of widely-used contraceptives and anti-inflammatory drugs, and it has sparked intense lobbying by the water and pharmaceutical industries which state that the science is uncertain and costs are too high.
EU member states, alarmed by the cost of estimates of tens of billions of euros, seem to have agreed. While researchers and environmentalists question these estimates, and argue that it should be judged on the strong scientific science behind it, rather than financial concerns.
Many of the EU’s rivers are home to male fish that are intersex, which means that they display female sexual characteristics, including female reproductive anatomy. Some males also produce vitellogenin, a protein found in eggs that can be induced in males by high hormone exposure. The UK found that in 2004, 86% of the fish sampled at 51 sites around the country were intersex.
Toxicologists think that this is due to the endocrine-disrupting chemicals, which are the active ingredient in contraceptive pills. Ethynyl oestradiol (EE2) is excreted by people using the contraceptive pill, and manages to get into the waterways.
In January, the EU proposed that its member states limit the drug’s annual average concentrations in surface waters to no more than 0.035 nanograms per liter. The European Commission also asked lawmakers to take action on diclofenac, an anti-inflammatory drug that disrupts cell function in the liver, kidneys, and gills of fish.
This EE2 standard would have represented a severe cut in pollution levels. If the European Parliament’s environment committee rejects the bill, then it would be doomed in the full parliamentary vote scheduled for next year. This outcome is now highly likely, based on previous committee discussions. The vote and discussion is set to take place on November 28.
Upgrading the wastewater treatment technology could eliminate most of the pollution. The water and pharmaceutical industries acknowledge that EE2 is present in rivers and that it is responsible for intersex fish. However, they state that there is little evidence of harm, noting that none of Europe’s freshwater fish populations are plummeting.
Some of the member states argue for more evidence of harmful effects, while some think that any standard for pharmaceuticals in water should be delayed until 2027.
A study on fathead minnows (Pimephales promelas) in a lake in Canada has shown that exposure to high levels of EE2 triggered a population crash.